Promotional pricing lifted test volume sharply, but margins fell and losses widened.
GRAIL, Inc. Common Stock (GRAL) News
Latest headlines that mention GRAL, newest first · each headline opens the original publisher
- Last price
- $129.93
- Day change
- +6.99%
- Next earnings
- —
GRAL headlines
latest coverageThe cancer blood test maker could have a bright future.
Galleri volume jumped 35% year over year on physician adoption and digital partnerships.
The developer of blood-based cancer tests still has a bright future.
GRAL news alerts
Get an alert by email or push when a new headline mentions GRAL.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.